| ID | Sequence | Length | GC content |
|---|---|---|---|
| ACAGAAGGAGGAAGGACAGCACAGCUGACAGCCGUGCUCAGACAGCUUC… | 1428 nt | 0.4419 | |
| ACAGAAGGAGGAAGGACAGCACAGCUGACAGCCGUGCUCAGACAGCUUC… | 1428 nt | 0.4475 | |
| ACAGAAGGAGGAAGGACAGCACAGCUGACAGCCGUGCUCAGACAGCUUC… | 1149 nt | 0.4291 | |
| ACAGAAGGAGGAAGGACAGCACAGCUGACAGCCGUGCUCAGACAGCUUC… | 2155 nt | 0.4863 | |
| ACAGAAGGAGGAAGGACAGCACAGCUGACAGCCGUGCUCAGACAGCUUC… | 1707 nt | 0.4552 |
The protein encoded by this gene is a member of the pregnancy-specific glycoprotein (PSG) family. This protein family and the closely related carcinoembryonic antigen cell adhesion molecule (CEACAM) gene family are both members of the immunoglobulin superfamily, and are organized as a large gene cluster. This protein is thought to inhibit platelet-fibrinogen interactions. Several studies suggest that reduced serum concentrations of PSGs are associated with fetal growth restrictions, while up-regulation of this gene has been observed in colorectal cancers. Several pseudogenes of this gene are found on chromosome 19. Alternative splicing results in multiple transcript variants that encode multiple protein isoforms. [provided by RefSeq, Sep 2014]
A study in humans evaluating placental mRNA markers for forensic pregnancy diagnostics found that the PSG9 showed no pregnancy-specific expression pattern in whole blood analysis [Gauvin et al. DOI:10.1007/S00414-008-0315-6].